AUPH - Aurinia Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

AUPH is currently covered by 5 analysts with an average price target of $15.33. This is a potential upside of $10.33 (206.6%) from yesterday's end of day stock price of $5.

Aurinia Pharmaceuticals's activity chart (see below) currently has 69 price targets and 53 ratings on display. The stock rating distribution of AUPH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.5% with an average time for these price targets to be met of 413.86 days.

Highest price target for AUPH is $13, Lowest price target is $8, average price target is $15.33.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 01-Mar-2024. First documented stock forecast 30-Jun-2016.

Best performing analysts who are covering AUPH - Aurinia Pharmaceuticals:

Alethia Young Ed Arce Elemer Piros Justin Kim Douglas Miehm Joseph Schwartz Ken Cacciatore

Currently out of the existing stock ratings of AUPH, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

13

$8.02 (161.04%)

13

1 months 18 days ago

10/21 (47.62%)

$7.22 (124.91%)

579

Buy

8

$3.02 (60.64%)

11

2 months 3 days ago

7/12 (58.33%)

$2.15 (36.75%)

135

Buy

13

1 years 5 months 15 days ago

5/9 (55.56%)

$4.73 (57.19%)

203

Buy

12

$7.02 (140.96%)

22

1 years 5 months 15 days ago

1/4 (25%)

$6.85 (133.01%)

266

Buy

35

$27.23 (350.45%)

30

2 years 8 months 13 days ago

1/2 (50%)

$17.83 (121.90%)

326

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AUPH (Aurinia Pharmaceuticals) average time for price targets to be met?

On average it took 413.86 days on average for the stock forecasts to be realized with a an average price target met ratio 59.5

Which analyst has the current highest performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?

ALETHIA YOUNG

Which analyst has the current lower performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?

KEN CACCIATORE

Which analyst has the most public recommendations on AUPH (Aurinia Pharmaceuticals)?

Alethia Young has 5 price targets and 5 ratings on AUPH

Which analyst is the currently most bullish on AUPH (Aurinia Pharmaceuticals)?

Alethia Young with highest potential upside - $29.02

Which analyst is the currently most reserved on AUPH (Aurinia Pharmaceuticals)?

Justin Kim with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?